Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Suvad Dedic
Glasgow Prognostic Score in Patients Receiving Chemotherapy for Non-Small-Cell Lung Cancer in Stages IIIb and IV
Medicinski Arhiv
Medicine
Related publications
Value of the Glasgow Prognostic Score as a Prognostic Factor in Resectable Non–Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P2.17-18 a Prognostic Score for Patients Receiving Multimodal Treatment for Locally-Advanced Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Chemotherapy for Non-Small Cell Lung Cancer in Elderly Patients
Chest
Cardiology
Critical Care
Cardiovascular Medicine
Intensive Care Medicine
Pulmonary
Respiratory Medicine
The Status of Immunosuppression in Patients With Stage IIIB or IV Non-Small-Cell Lung Cancer Correlates With the Clinical Characteristics and Response to Chemotherapy
OncoTargets and Therapy
Oncology
Pharmacology
Nursing Care for Patients With Non-Small Cell Lung Cancer Receiving Adjuvant Chemotherapy: Evidence–based Implications for Practice
Canadian Oncology Nursing Journal
Prognostic Gene Signatures for Non-Small-Cell Lung Cancer
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
P1.17-02 Low Prognostic Nutritional Index Predicts Poor Survival in Stage IIIB Non-Small Cell Lung Cancer Patients Treated With Chemoradiotherapy
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Prognostic Impact of Missed Chemotherapy Doses During Chemoradiation Therapy for Non–Small Cell Lung Cancer
American Journal of Clinical Oncology: Cancer Clinical Trials
Cancer Research
Oncology
P2.01-80 Performance Status and Resource Utilization in Patients Receiving Palliaitve Care With Stage IV Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
